Opioid Peptides Can Block Estrogen-Driven Cell Growth in the Uterus
An enkephalin analog inhibited estrogen-induced uterine DNA synthesis by about 50% in rats, and naloxone partially reversed it — showing opioid control over estrogen-driven tissue growth.
Quick Facts
What This Study Found
DMEPA (enkephalin analog) inhibited estradiol-induced uterine DNA synthesis by ~50% when given 1-2 hours before measurement. Naloxone partially reversed the effect.
Key Numbers
How They Did This
Ovariectomized rats received estradiol injection followed by DMEPA at various time points. Uterine DNA synthesis was measured by in vitro thymidine incorporation 24 hours after estradiol.
Why This Research Matters
This shows opioid peptides can suppress estrogen-driven tissue growth. This could be relevant to conditions like endometriosis and uterine cancer where estrogen-driven growth is a problem.
The Bigger Picture
Estrogen-driven tissue growth is central to endometriosis, uterine fibroids, and some cancers. If opioid peptides can naturally restrain this growth, they could inspire new treatments for these conditions.
What This Study Doesn't Tell Us
Animal study in ovariectomized rats, which is an artificial hormonal state. Only one enkephalin analog tested. The mechanism of growth inhibition was not fully characterized.
Questions This Raises
- ?Could opioid-based drugs be developed to treat estrogen-driven conditions like endometriosis?
- ?Is the natural opioid system normally keeping uterine growth in check?
Trust & Context
- Key Stat:
- ~50% inhibition The enkephalin analog DMEPA halved estrogen-induced uterine DNA synthesis within a narrow time window
- Evidence Grade:
- Preliminary — animal study in ovariectomized rats using a single opioid analog. Demonstrates the phenomenon but mechanism not fully characterized.
- Study Age:
- Published in 1992 (34 years ago). Opioid-estrogen interactions in reproductive tissues remain an area of ongoing research.
- Original Title:
- Inhibition of oestradiol-induced DNA synthesis by opioid peptides in the rat uterus.
- Published In:
- Life sciences, 51(15), 1187-96 (1992)
- Database ID:
- RPEP-00243
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why would opioids affect uterine growth?
The uterus has opioid receptors, and opioid peptides can modulate how cells respond to estrogen. By inhibiting DNA synthesis, opioids may serve as a natural check on estrogen-driven tissue growth.
Could this help treat endometriosis?
Potentially. Endometriosis involves estrogen-driven growth of uterine-like tissue. If opioid peptides can suppress this growth — as this study suggests — they could inspire new therapeutic approaches.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00243APA
Ordög, T; Vértes, Z; Vértes, M. (1992). Inhibition of oestradiol-induced DNA synthesis by opioid peptides in the rat uterus.. Life sciences, 51(15), 1187-96.
MLA
Ordög, T, et al. "Inhibition of oestradiol-induced DNA synthesis by opioid peptides in the rat uterus.." Life sciences, 1992.
RethinkPeptides
RethinkPeptides Research Database. "Inhibition of oestradiol-induced DNA synthesis by opioid pep..." RPEP-00243. Retrieved from https://rethinkpeptides.com/research/ordog-1992-inhibition-of-oestradiolinduced-dna
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.